Conrad Chan

111In-Labeled Trastuzumab (Herceptin) Modified with Nuclear Localization Sequences (NLS): An Auger Electron-Emitting Radiotherapeutic Agent for HER2/neu-Amplified Breast Cancer

D. L. Costantini, Conrad Chan, Zhongli Cai et al. · Journal of Nuclear Medicine · 2007 · 188 citations · Full text

Medicine, Oncology, Pharmacology +17

Optimized digital counting colonies of clonogenic assays using ImageJ software and customized macros: Comparison with manual counting

Zhongli Cai, Niladri Chattopadhyay, Wenchao Jessica Liu et al. · International Journal of Radiation Biology · 2011 · 126 citations

Medicine, Cancer Biology, Oncology +17

Cellular Dosimetry of ¹¹¹In Using Monte Carlo N-Particle Computer Code: Comparison with Analytic Methods and Correlation with In Vitro Cytotoxicity

Zhongli Cai, Jean‐Philippe Pignol, Conrad Chan et al. · Journal of Nuclear Medicine · 2010 · 68 citations · Full text

Medicine, Cancer Biology, Radiation Oncology +17

Development and preclinical studies of ⁶⁴Cu-NOTA-pertuzumab F(ab′)₂ for imaging changes in tumor HER2 expression associated with response to trastuzumab by PET/CT

Karen Lam, Conrad Chan, Raymond M. Reilly · mAbs · 2016 · 48 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Dual-Receptor–Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using ¹⁷⁷Lu- or ¹¹¹In-Labeled Bispecific Radioimmunoconjugates

Eva J. Razumienko, J. Chen, Zhongli Cai et al. · Journal of Nuclear Medicine · 2015 · 47 citations · Full text

Medicine, Oncology, Pharmacology +17